Publications of Issa F Khouri - MD Anderson Cancer Center

189 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Simrit Parmar; Gabriela Rondon; Marcos de Lima; Peter Thall; Ronald Bassett; Paolo Anderlini; Partow Kebriaei; Issa Khouri; Prasanth Ganesan; Richard Champlin; et al.

Dose Intensification of Busulfan in the Preparative Regimen is Associated with Improved Survival: A Phase I/II Controlled, Randomized Study
Biology of Blood and Marrow Transplantation. 2013;19(3):474-480.

0
2.
2013

Yago Nieto; Uday Popat; Paolo Anderlini; Ben Valdez; Borje Andersson; Ping Liu; Chitra Hosing; Elizabeth J. Shpall; Amin Alousi; Partow Kebriaei; et al.

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation. 2013;19(3):410-417.

0
3.
2013

Elias Jabbour; Michael S. Mathisen; Guillermo Garcia-Manero; Richard Champlin; Uday Popat; Issa Khouri; Sergio Giralt; Tapan Kadia; Julianne Chen; Sherry Pierce; et al.

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case-control study
American Journal of Hematology. 2013;88(3):198-200.

0
4.
2013

Fleur M. Aung; Benjamin Lichtiger; Roland Bassett; Ping Liu; Amin Alousi; Qaiser Bashier; Stefan O. Ciurea; Marcos J. de Lima; Chitra Hosing; Partow Kebriaei; et al.

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation
British Journal of Haematology. 2013;160(6):798-805.

0
5.
2013

Betul Oran; Uday Popat; Gabriella Rondon; Farhad Ravandi; Guillermo Garcia-Manero; Lynn Abruzzo; Borje S. Andersson; Qaiser Bashir; Julianne Chen; Partow Kebriaei; et al.

Significance of Persistent Cytogenetic Abnormalities on Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission
Biology of Blood and Marrow Transplantation. 2013;19(2):214-220.

1
6.
2012

Stefan O. Ciurea; Victor Mulanovich; Rima M. Saliba; Ulas D. Bayraktar; Ying Jiang; Roland Bassett; Sa A. Wang; Marina Konopleva; Marcelo Fernandez-Vina; Nivia Montes; et al.

Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation. 2012;18(12):1835-1844.

3
7.
2012

Partow Kebriaei; Roland Basset; C. Ledesma; S. Ciurea; S. Parmar; E.J. Shpall; C. Hosing; Issa Khouri; M. Qazilbash; U. Popat; et al.

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation. 2012;18(12):1819-1826.

0
8.
2012

Yago Nieto; Peter Thall; Ben Valdez; Borje Andersson; Uday Popat; Paolo Anderlini; Elizabeth J. Shpall; Roland Bassett; Amin Alousi; Chitra Hosing; et al.

High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphoid Malignancies
Biology of Blood and Marrow Transplantation. 2012;18(11):1677-1686.

2
9.
2012

Issa F. Khouri; Richard E. Champlin

Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma
Cancer Journal (United States). 2012;18(5):457-462.

0
10.
2012

Issa F. Khouri; Rima M. Saliba; William D. Erwin; Barry I. Samuels; Martin Korbling; L. Jeffrey Medeiros; Rosamar Valverde; Amin M. Alousi; Paolo Anderlini; Qaiser Bashir; et al.

Nonmyeloablative allogeneic transplantation with or without ⁹⁰yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
Blood. 2012;119(26):6373-6378.

4
11.
2012

Paolo Anderlini; Rima M. Saliba; Celina Ledesma; Christina Chancoco; Amin M. Alousi; Elizabeth J. Shpall; Uday R. Popat; Chitra M. Hosing; Issa F. Khouri; Yago Nieto; et al.

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results
Leukemia and Lymphoma. 2012;53(3):499-502.

0
12.
2012

U. Popat; M.J. De Lima; R.M. Saliba; P. Anderlini; B.S. Andersson; A.M. Alousi; C. Hosing; Y. Nieto; S. Parmar; I.F. Khouri; et al.

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR
Bone Marrow Transplantation. 2012;47(2):212-216.

0
13.
2011

Gheath Alatrash; Matteo Pelosini; Rima M. Saliba; Ebru Koca; Gabriela Rondon; Borje S. Andersson; Alexandre Chiattone; Weiqing Zhang; Sergio A. Giralt; Amanda M. Cernosek; et al.

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome
Biology of Blood and Marrow Transplantation. 2011;17(12):1841-1845.

0
14.
2011

Issa F. Khouri; Roland Bassett; Nancy Poindexter; Susan O'Brien; Carlos E. Bueso-Ramos; Yvonne Hsu; Alessandra Ferrajoli; Michael J. Keating; Richard Champlin; Marcelo Fernandez-Vina

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: Long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome
Cancer. 2011;117(20):4679-4688.

11
15.
2011

Issa F. Khouri

Allogeneic stem cell transplantation in follicular lymphoma
Best Practice and Research: Clinical Haematology. 2011;24(2):271-277.

1
16.
2011

Chitra Hosing; Veronica Smith; Beverly Rhodes; Kent Walters; Richmond Thompson; Muzaffar Qazilbash; Issa Khouri; Marcos De Lima; Richard J. Balzer; John McMannis; et al.

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation
Transfusion. 2011;51(6):1300-1313.

2
17.
2011

Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F. Thall; Celina Ledesma; Yago Nieto; Elizabeth J. Shpall; Chitra Hosing; Muzaffar Qazilbash; et al.

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies
Biology of Blood and Marrow Transplantation. 2011;17(3):412-420.

7
18.
2011

Jason R. Westin; Rima M. Saliba; Marcos De Lima; Amin Alousi; Chitra Hosing; Muzaffar H. Qazilbash; Issa F. Khouri; Elizabeth J. Shpall; Paolo Anderlini; Gabriela Rondon; et al.

Steroid-refractory acute GVHD: Predictors and outcomes
Advances in Hematology. 2011;2011.

1
19.
2010

Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J. Borowitz; Peter Dreger; Issa Khouri; Eduardo Olavarria; Jerald Radich; Wendy Stock; et al.

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. Part II: Chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
Biology of Blood and Marrow Transplantation. 2010;16(10):1325-1346.

10
20.
2010

Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J. Borowitz; Peter Dreger; Issa Khouri; Homer Macapintac; Eduardo Olavarria; et al.

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes
Biology of Blood and Marrow Transplantation. 2010;16(9):1187-1211.

23
21.
2010

Yvonne A. Efebera; Sofia R. Qureshi; Suzanne M. Cole; Rima Saliba; Matteo Pelosini; Ronak M. Patel; Ebru Koca; Floralyn L. Mendoza; Michael Wang; Jatin Shah; et al.

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
Biology of Blood and Marrow Transplantation. 2010;16(8):1122-1129.

3
22.
2010

Madeleine Duvic; Michele Donato; Bouthaina Dabaja; Heather Richmond; Lotika Singh; Wei Wei; Sandra Acholonu; Issa Khouri; Richard Champlin; Chitra Hosing

Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sézary syndrome
Journal of Clinical Oncology. 2010;28(14):2365-2372.

27
23.
2010

A. Safdar; G.H. Rodriguez; C.N. Mihu; L. Mora-Ramos; V. Mulanovich; R.F. Chemaly; R.E. Champlin; I. Khouri

Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: Spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
Bone Marrow Transplantation. 2010;45(2):339-347.

5
24.
2009

Daniel R. Couriel; Rima Saliba; Marcos de Lima; Sergio Giralt; Borje Andersson; Issa Khouri; Chitra Hosing; Cindy Ippoliti; Elizabeth J. Shpall; Richard Champlin; et al.

A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation. 2009;15(12):1555-1562.

13
25.
2009

Yee Chung Cheng; Gabriela Rondón; Leah F. Sanchez; John D. McMannis; Daniel R. Couriel; Marcos J. De Lima; Chitra Hosing; Issa F. Khouri; Sergio A. Giralt; Richard E. Champlin; et al.

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
International Journal of Hematology. 2009;90(5):627-634.

2
26.
2009

Uday Popat; Rima Saliba; Rupinderjit Thandi; Chitra Hosing; Muzaffar Qazilbash; Paolo Anderlini; Elizabeth Shpall; John McMannis; Martin Körbling; Amin Alousi; et al.

Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma
Biology of Blood and Marrow Transplantation. 2009;15(6):718-723.

42
27.
2009

Chitra Hosing; Rima M. Saliba; Sheena Ahlawat; Martin Körbling; Partow Kebriaei; Amin Alousi; Marcos De Lima; Julia-Grace Okoroji; John McMannis; Muzaffar Qazilbash; et al.

Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma
American Journal of Hematology. 2009;84(6):335-337.

26
28.
2009

Carlos A. Ramos; Rima M. Saliba; Leandro De Pádua; Ola Khorshid; Elizabeth J. Shpall; Sergio Giralt; Poliana A. Patah; Chitra M. Hosing; Uday R. Popat; Gabriela Rondon; et al.

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Haematologica. 2009;94(2):249-257.

10
29.
2009

Constantine S. Tam; Roland Bassett; Celina Ledesma; Martin Korbling; Amin Alousi; Chitra Hosing; Partow Kebraei; Robyn Harrell; Gabriela Rondon; Sergio A. Giralt; et al.

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma
Blood. 2009;113(18):4144-4152.

68
30.
2009

Constantine S. Tam; Issa F. Khouri

Autologous and allogeneic stem cell transplantation: Rising therapeutic promise for mantle cell lymphoma
Leukemia and Lymphoma. 2009;50(8):1239-1248.

5
31.
2009

Julie M. Vose; Anthony D. Ho; Bertrand Coiffier; Paolo Corradini; Issa Khouri; Anna Sureda; Koen Van Besien; John Dipersio

Advances in mobilization for the optimization of autologous stem cell transplantation
Leukemia and Lymphoma. 2009;50(9):1412-1421.

18
32.
2009

Constantine S. Tam; Issa Khouri

The role of stem cell transplantation in the management of chronic lymphocytic leukaemia
Hematological Oncology. 2009;27(2):53-60.

6
33.
2008

Hillard M. Lazarus; Jeanette Carreras; Christian Boudreau; Fausto R. Loberiza Jr.; James O. Armitage; Brian J. Bolwell; César O. Freytes; Robert Peter Gale; John Gibson; Gregory A. Hale; et al.

Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)
Biology of Blood and Marrow Transplantation. 2008;14(12):1323-1333.

7
34.
2008

Issa F. Khouri

Response: Choice of conditioning for allogeneic transplantation in follicular lymphoma: Nonmyeloablative or high-dose chemotherapy?
Blood. 2008;112(6):2586-2587.

0
35.
2008

Amin M. Alousi; Rima M. Saliba; Grace-Julia Okoroji; Homer A. Macapinlac; Chitra Hosing; Martin Korbling; Barry I. Samuels; Uday Popat; Partow Kebriaei; Paolo Anderlini; et al.

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation
British Journal of Haematology. 2008;142(5):786-792.

11
36.
2008

Gabriela Rondón; Rima M. Saliba; Issa Khouri; Sergio Giralt; Kawah Chan; Elias Jabbour; John McMannis; Richard Champlin; Elizabeth Shpall

Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution Analysis
Biology of Blood and Marrow Transplantation. 2008;14(8):859-866.

10
37.
2008

H.J. Lee; A. Gulbis; L. De Padua Silva; C. Hosing; I. Khouri; M. de Lima; R.E. Champlin; S.O. Ciurea

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT
Bone Marrow Transplantation. 2008;42(1):67-69.

13
38.
2008

Issa F. Khouri; Peter McLaughlin; Rima M. Saliba; Chitra Hosing; Martin Korbling; Ming S. Lee; L. Jeffrey Medeiros; Luis Fayad; Felipe Samaniego; Amin Alousi; et al.

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Blood. 2008;111(12):5530-5536.

129
39.
2008

C. Hosing; R.M. Saliba; G.-J. Okoroji; U. Popat; D. Couriel; T. Ali; L. De Padua Silva; P. Kebriaei; A. Alousi; M. De Lima; et al.

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age
Annals of Oncology. 2008;19(6):1166-1171.

13
40.
2008

M. de Lima; J. McMannis; A. Gee; K. Komanduri; D. Couriel; B.S. Andersson; C. Hosing; I. Khouri; R. Jones; R. Champlin; et al.

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: A phase I/II clinical trial
Bone Marrow Transplantation. 2008;41(9):771-778.

77
41.
2008

M. de Lima; R.E. Champlin; P.F. Thall; X. Wang; T.G. Martin III; J.D. Cook; G. McCormick; M. Qazilbash; P. Kebriaei; D. Couriel; et al.

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome
Leukemia. 2008;22(2):258-264.

22
42.
2008

Paolo Anderlini; Rima Saliba; Sandra Acholonu; Sergio A. Giralt; Borje Andersson; Naoto T. Ueno; Chitra Hosing; Issa F. Khouri; Daniel Couriel; Marcos De Lima; et al.

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: The updated M.D. Anderson Cancer Center experience
Haematologica. 2008;93(2):257-264.

50
43.
2008

Matthew C. Fox; Samantha Carter; Issa F. Khouri; Sergio A. Giralt; Victor G. Prieto; Jason W. Nash; Sharon R. Hymes

Adult henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma
Cutis. 2008;81(2):131-137.

1
44.
2007

S.Z. Pavletic; G. Zhou; K. Sobocinski; G. Marti; K. Doney; J. DiPersio; W. Feremans; L. Foroni; S. Goodman; G. Prentice; et al.

Genetically identical twin transplantation for chronic lymphocytic leukemia
Leukemia. 2007;21(12):2452-2455.

9
45.
2007

B. Oran; S. Giralt; D. Couriel; C. Hosing; E.J. Shpall; E. de Meis; I.F. Khouri; M. Qazilbash; P. Anderlini; P. Kebriaei; et al.

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation [3]
Leukemia. 2007;21(12):2540-2544.

15
46.
2007

Constantine S. Tam; Issa Khouri

Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma
Current Hematologic Malignancy Reports. 2007;2(4):225-231.

1
47.
2007

Partow Kebriaei; Michelle A. Detry; Sergio Giralt; Antonio Carrasco-Yalan; Athanasios Anagnostopoulos; Daniel Couriel; Issa F. Khouri; Paolo Anderlini; Chitra Hosing; Amin Alousi; et al.

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia
Blood. 2007;110(9):3456-3462.

27
48.
2007

Constantine S. Tam; Susan O'Brien; Susan Lerner; I. Khouri; A. Ferrajoli; S. Faderl; M. Browning; Apostolia M. Tsimberidou; Hagop Kantarjian; William G. Wierda

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy
Leukemia and Lymphoma. 2007;48(10):1931-1939.

39
49.
2007

E. Jabbour; G. Rondon; P. Anderlini; S.A. Giralt; D.R. Couriel; R.E. Champlin; I.F. Khouri

Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation
Bone Marrow Transplantation. 2007;40(5):431-435.

18
50.
2007

E. Özdemir; R.M. Saliba; R.E. Champlin; D.R. Couriel; S.A. Giralt; M. de Lima; I.F. Khouri; C. Hosing; S.M. Kornblau; P. Anderlini; et al.

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
Bone Marrow Transplantation. 2007;40(2):125-136.

31
51.
2007

Elias Jabbour; Chitra Hosing; Gregory Ayers; Rodolfo Nunez; Paolo Anderlini; Barbara Pro; Issa Khouri; Anas Younes; Fredrick Hagemeister; Larry Kwak; et al.

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory hodgkin lymphoma
Cancer. 2007;109(12):2481-2489.

56
52.
2007

Issa F. Khouri; Rima M. Saliba; Joan Admirand; Susan O'Brien; Ming-S. Lee; Martin Korbling; Barry I. Samuels; Sergio Giralt; De Marcos Lima; Michael J. Keating; et al.

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia
British Journal of Haematology. 2007;137(4):355-363.

46
53.
2007

Betul Oran; Sergio Giralt; Rima Saliba; Chitra Hosing; Uday Popat; Issa Khouri; Daniel Couriel; Muzaffar Qazilbash; Paolo Anderlini; Partow Kebriaei; et al.

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan
Biology of Blood and Marrow Transplantation. 2007;13(4):454-462.

49
54.
2007

Rima M. Saliba; Marcos De Lima; Sergio Giralt; Borje Andersson; Issa F. Khouri; Chitra Hosing; Shubhra Ghosh; Joyce Neumann; Yvonne Hsu; Jorge De Jesus; et al.

Hyperacute GVHD: Risk factors, outcomes, and clinical implications
Blood. 2007;109(7):2751-2758.

27
55.
2007

A. Safdar; G. Rodriguez; K.V.I. Rolston; S. O'Brien; I F. Khouri; E.J. Shpall; M.J. Keating; H.M. Kantarjian; R.E. Champlin; et al.

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
Bone Marrow Transplantation. 2007;39(3):157-164.

17
56.
2006

Apostolia-Maria Tsimberidou; Issa Khouri; Michael J. Keating

Richter's syndrome: A report on response, survival, failure-free survival, and prognostic factors
American Journal of Oncology Review. 2006;5(11):662-665.

0
57.
2006

Martin Körbling; James M. Reuben; Hui Gao; Bang-Ning Lee; David M. Harris; David Cogdell; Sergio A. Giralt; Issa F. Khouri; Rima M. Saliba; Richard E. Champlin; et al.

Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: A novel blood cell component for therapeutic vasculogenesis
Transfusion. 2006;46(10):1795-1802.

41
58.
2006

Alberto J. Montero; Zeev Estrov; Emil J. Freireich; Issa F. Khouri; Charles A. Koller; Razelle Kurzrock

Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome
Leukemia and Lymphoma. 2006;47(10):2049-2054.

9
59.
2006

Malisha R. Johnson; Daniel Del Carpio-Jayo; Pei Lin; Sergio Giralt; Paolo Anderlini; Richard E. Champlin; Issa F. Khouri; Saroj Vadhan-Raj; L. Jeffrey Medeiros; Carlos E. Bueso-Ramos

Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation
Annals of Diagnostic Pathology. 2006;10(5):263-268.

16
60.
2006

L. Lekakis; S. Giralt; D. Couriel; E.J. Shpall; C. Hosing; I.F. Khouri; P. Anderlini; M. Korbling; T. Martin; R.E. Champlin; et al.

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies
Bone Marrow Transplantation. 2006;38(6):421-426.

25
61.
2006

P. Kebriaei; R.M. Saliba; C. Ma; C. Ippoliti; D.R. Couriel; M. de Lima; S. Giralt; M.H. Qazilbash; J.L. Gajewski; C.S. Ha; et al.

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
Bone Marrow Transplantation. 2006;38(3):203-209.

25
62.
2006

Chitra Hosing; Rima M. Saliba; Martin Körbling; Sandra Acholonu; John Mcmannis; Paolo Anderlini; Sergio Giralt; Marcos De Lima; Grace-Julia Okoroji; Daniel R. Couriel; et al.

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma
Leukemia and Lymphoma. 2006;47(7):1290-1294.

10
63.
2006

Apostolia-Maria Tsimberidou; Susan O'Brien; Issa Khouri; Francis J. Giles; Hagop M. Kantarjian; Richard Champlin; Sijin Wen; Kim-Anh Do; Susan C. Smith; Susan Lerner; et al.

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation
Journal of Clinical Oncology. 2006;24(15):2343-2351.

49
64.
2006

Daniel R. Couriel; Chitra Hosing; Rima Saliba; Elizabeth J. Shpall; Paolo Anderlini; Beverly Rhodes; Veronica Smith; Issa Khouri; Sergio Giralt; Marcos De Lima; et al.

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD
Blood. 2006;107(8):3074-3080.

98
65.
2006

Issa F Khouri

Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2006:390-397.

29
66.
2005

D.R. Couriel; R. Saliba; M.P. Escalón; Y. Hsu; S. Ghosh; C. Ippoliti; K. Hicks; M. Donato; S. Giralt; I.F. Khouri; et al.

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease
British Journal of Haematology. 2005;130(3):409-417.

80
67.
2005

Panderli Anderlini; R. Saliba; S. Acholonu; G.-J. Okoroji; M. Donato; S. Giralt; B. Andersson; N.T. Ueno; I. Khouri; M. De Lima; et al.

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: Low transplant-related mortality and impact of intensity of conditioning regimen
Bone Marrow Transplantation. 2005;35(10):943-951.

70
68.
2005

Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F. Thall; Marcos de Lima; Issa Khouri; James Gajewski; Jorge Alamo; Daniel Couriel; Borje S. Andersson; et al.

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
Biology of Blood and Marrow Transplantation. 2005;11(2):108-114.

45
69.
2005

Issa F. Khouri; Rima M. Saliba; Chitra Hosing; Grace-Julia Okoroji; Sandra Acholonu; Paolo Anderlini; Daniel Couriel; Marcos De Lima; Michele L. Donato; Luis Fayad; et al.

Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
Journal of Clinical Oncology. 2005;23(10):2240-2247.

85
70.
2005

A.-M. Tsimberidou; F.J. Giles; I. Khouri; C. Bueso-Ramos; S. Pilat; D.A. Thomas; J. Cortes; R. Kurzrock

Low-dose interleukin-11 in patients with bone marrow failure: Update of the M. D. Anderson Cancer Center experience
Annals of Oncology. 2005;16(1):139-145.

24
71.
2005

Steven Z. Pavletic; Issa F. Khouri; Michael Haagenson; Roberta J. King; Philip J. Bierman; Michael R. Bishop; Michael Carston; Sergio Giralt; Arturo Molina; Edward A. Copelan; et al.

Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: Results from the center for international blood and marrow transplant research
Journal of Clinical Oncology. 2005;23(24):5788-5794.

53
72.
2004

P. Anderlini; S.A. Acholonu; G.-J. Okoroji; B.S. Andersson; D.R. Couriel; M.J. De Lim; M.L. Donato; I.F. Khouri; S.A. Giralt; N.T. Ueno; et al.

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response
Bone Marrow Transplantation. 2004;34(6):511-514.

24
73.
2004

Daniel Couriel; Rima Saliba; Krystal Hicks; Cindy Ippoliti; Marcos De Lima; Chitra Hosing; Issa Khouri; Borje Andersson; James Gajewski; Michele Donato; et al.

Tumor necrosis factor-α blockade for the treatment of acute GVHD
Blood. 2004;104(3):649-654.

144
74.
2004

E. Jabbour; M.J. Keating; R.E. Champlin; I.F. Khouri

Stem cell transplantation for chronic lymphocytic leukemia: Should not more patients get a transplant?
Bone Marrow Transplantation. 2004;34(4):289-297.

15
75.
2004

Maha El-Zimaity; Rima Saliba; Kawah Chan; Munir Shahjahan; Antonio Carrasco; Ola Khorshid; Humberto Caldera; Daniel Couriel; Sergio Giralt; Issa Khouri; et al.

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: Donor type matters
Blood. 2004;103(12):4674-4680.

42
76.
2004

Koen Van Besien; Rakesh Mehra; Navin Wadehra; Wendy Stock; Issa Khouri; Sergio Giralt; Steve Devine; Amittha Wickrema; David Peace; et al.

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma
Biology of Blood and Marrow Transplantation. 2004;10(6):386-394.

6
77.
2004

U. Popat; C. Hosing; R.M. Saliba; P. Anderlini; K. van Besien; D. Przepiorka; I.F. Khouri; J. Gajewski; D. Claxton; S. Giralt; et al.

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
Bone Marrow Transplantation. 2004;33(10):1015-1023.

18
78.
2004

Jun Gu; Yang O. Huh; Feng Jiang; Nancy P. Caraway; Jorge E. Romaguera; Tanweer M. Zaidi; Ricardo L. Fernandez; Huazhong Zhang; Issa F. Khouri; Ruth L. Katz

Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings
Modern Pathology. 2004;17(5):553-560.

6
79.
2004

I.F. Khouri; M. Albitar; R.M. Saliba; C. Ippoliti; Y.C. Ma; M.J. Keating; R.E. Champlin

Low-dose alemtuzumab (Campath®) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: Decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics
Bone Marrow Transplantation. 2004;33(8):833-837.

23
80.
2004

Daniel R. Couriel; Rima M. Saliba; Sergio Giralt; Issa Khouri; Borje Andersson; Marcos de Lima; Chitra Hosing; Paolo Anderlini; Michelle Donato; Karen Cleary; et al.

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
Biology of Blood and Marrow Transplantation. 2004;10(3):178-185.

107
81.
2004

Issa F. Khouri; Richard E. Champlin

Nonmyeloablative Stem Cell Transplantation for Lymphoma
Seminars in Oncology. 2004;31(1):22-26.

22
82.
2004

Maricer P. Escalón; Richard E. Champlin; Rima M. Saliba; Sandra A. Acholonu; Chitra Hosing; Luis Fayad; Sergio Giralt; Naoto T. Ueno; Farzaneh Maadani; Barbara Pro; et al.

Nonmyeloablative allogeneic hematopoietic transplantation: A promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
Journal of Clinical Oncology. 2004;22(12):2419-2423.

79
83.
2004

Issa F. Khouri; Ming-Sheng Lee; Rima M. Saliba; Borje Andersson; Paolo Anderlini; Daniel Couriel; Chitra Hosing; Sergio Giralt; Martin Korbling; John McMannis; et al.

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: Impact of rituximab on immunomodulation and survival
Experimental Hematology. 2004;32(1):28-35.

96
84.
2003

Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard E. Champlin

Long-Term Follow-Up of Autologous Stem Cell Transplantation in Patients with Diffuse Mantle Cell Lymphoma in First Disease Remission: The Prognostic Value of β₂-Microglobulin and the Tumor Score
Cancer. 2003;98(12):2630-2635.

65
85.
2003

Issa F. Khouri; Ming-S. Lee; Rima M. Saliba; Gu Jun; Luis Fayad; Anas Younes; Barbara Pro; Sandra Acholonu; Peter McLaughlin; Ruth L. Katz; et al.

Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma
Journal of Clinical Oncology. 2003;21(23):4407-4412.

123
86.
2003

O. Khorshid; E. de Meis; T. Martin; R.B. Jones; E.J. Shpall; Y. Nieto; I. Khouri; M. Shahjahan; J. Gajewski; S. Giralt; et al.

Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant [7]
Leukemia. 2003;17(12):2538-2540.

4
87.
2003

Naoto T. Ueno; Yee Chung Cheng; Gabriela Rondón; Nizar M. Tannir; James L. Gajewski; Daniel R. Couriel; Chitra Hosing; Marcos J. De Lima; Paolo Anderlini; Issa F. Khouri; et al.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors
Blood. 2003;102(10):3829-3836.

118
88.
2003

Raymond Wong; Marcos De Lima; Daniel Couriel; Sergio Giralt; Chitra Hosing; Munir Shahjahan; Yee Chung Cheng; Jill Bruton; Richard Champlin; Issa Khouri

Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab
Leukemia and Lymphoma. 2003;44(5):829-832.

1
89.
2003

C. Hosing; R.M. Saliba; P. McLaughlin; B. Andersson; M.A. Rodriguez; L. Fayad; F. Cabanillas; R.E. Champlin; I.F. Khouri

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma
Annals of Oncology. 2003;14(5):737-744.

48
90.
2003

N. Apisarnthanarax; M. Donato; M. Körbling; D. Couriel; J. Gajewski; S. Giralt; I. Khouri; C. Hosing; R. Champlin; M. Duvic; et al.

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: Feasibility and results
Bone Marrow Transplantation. 2003;31(6):459-465.

62
91.
2003

Marcos De Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel; Michele Donato; Issa Khouri; James Gajewski; Koen Van Besien; Richard Champlin; et al.

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
Cancer. 2003;97(5):1242-1247.

26
92.
2003

Champlin Richard; Issa Khouri; Paolo Anderlini; Marcos De Lima; Chitra Hosing; John McMannis; Jeffrey Molldrem; Naoto Ueno; Sergio Giralt

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: Biology and current indications
ONCOLOGY. 2003;17(1):94-100.

0
93.
2003

Richard Champlin; Issa Khouri; Paolo Anderlini; Marcos De Lima; Chitra Hosing; John McMannis; Jeffrey Molldrem; Naoto Ueno; Sergio Giralt

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.). 2003;17(1):94-100; discussion 103.

21
94.
2002

S. Giralt; A. Aleman; A. Anagnostopoulos; D. Weber; I. Khouri; P. Anderlini; J. Molldrem; N.T. Ueno; M. Donato; M. Korbling; et al.

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma
Bone Marrow Transplantation. 2002;30(6):367-373.

97
95.
2002

Issa Khouri; Bertrand Tuan; Kathleen Grant; Jack J.H. Bleesing; Thomas A. Fleisher; Leo J. McCarthy; Walter Dzik; Douglas B. Cines; Victor S. Blanchette

Immune thrombocytopenic purpura [6] (multiple letters)
New England Journal of Medicine. 2002;347(6):449-450.

4
96.
2002

Nicolas Mounier; Daniele Simon; Corinne Haioun; Philippe Gaulard; Christian Gisselbrecht; Issa Khouri

Impact of high-dose chemotherapy on peripheral T-cell lymphomas [2] (multiple letters)
Journal of Clinical Oncology. 2002;20(5):1426-1427.

23
97.
2002

Issa F. Khouri; M.J. Keating; R.M. Saliba; R.E. Champlin

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation
Cytotherapy. 2002;4(3):217-221.

54
98.
2002

C. Hosing; M. Munsell; S. Yazji; B. Andersson; D. Couriel; M. de Lima; M. Donato; J. Gajewski; S. Giralt; M. Körbling; et al.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma
Annals of Oncology. 2002;13(3):450-459.

31
99.
2002

I. Barista; F. Cabanillas; J.E. Romaguera; I.F. Khouri; Y. Yang; T.L. Smith; S.S. Strom; L.J. Medeiros; F.B. Hagemeister

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?
Annals of Oncology. 2002;13(2):318-322.

13
100.
2002

Issa Khouri; Sergio Giralt; Richard Champlin

Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
Cancer treatment and research. 2002;110:137-147.

6
101.
2002

James L Gajewski; Gabriela Rondon; Michele L Donato; Paolo Anderlini; Martin Korbling; Cindy Ippoliti; Mark Benyunes; Langdon L Miller; Denise LaTemple; Denny Jones; et al.

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor peripheral blood progenitor cell mobilization
Biology of Blood and Marrow Transplantation. 2002;8(10):550-556.

11
102.
2001

Issa F. Khouri; Rima M. Saliba; Sergio A. Giralt; Ming-Sheng Lee; Grace-Julia Okoroji; Fredrick B. Hagemeister; Martin Korbling; Anas Younes; Cindy Ippoliti; James L. Gajewski; et al.

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Blood. 2001;98(13):3595-3599.

270
103.
2001

Ramesh Gopal; Chul S. Ha; Susan L. Tucker; Issa F. Khouri; Sergio A. Giralt; James L. Gajewski; Borje S. Andersson; James D. Cox; Richard E. Champlin

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
Cancer. 2001;92(7):1949-1958.

25
104.
2001

Donna Przepiorka; Paolo Anderlini; Rima Saliba; Karen Cleary; Rakesh Mehra; Issa Khouri; Yang O. Huh; Sergio Giralt; Ira Braunschweig; Koen Van Besien; et al.

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
Blood. 2001;98(6):1695-1700.

123
105.
2001

J. Rodriguez; M. Munsell; S. Yazji; F.B. Hagemeister; A. Younes; B. Andersson; S. Giralt; J. Gajewski; M. De Lima; D. Couriel; et al.

Impact of high-dose chemotherapy on peripheral T-cell lymphomas
Journal of Clinical Oncology. 2001;19(17):3766-3770.

108
106.
2001

Sergio Giralt; Peter F. Thall; Issa Khouri; Xuemei Wang; Ira Braunschweig; Cindy Ippolitti; David Claxton; Michele Donato; Jill Bruton; Agueda Cohen; et al.

Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
Blood. 2001;97(3):631-637.

430
107.
2001

A. Shimoni; T.L. Smith; A. Aleman; D. Weber; M. Dimopoulos; P. Anderlini; B. Andersson; D. Claxton; N.T. Ueno; I. Khouri; et al.

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: An intensive regimen for the treatment of multiple myeloma
Bone Marrow Transplantation. 2001;27(8):821-828.

18
108.
2001

M. Körbling; S. Giralt; I. Khouri; N. Mirza; M. Donato; P. Anderlini; H. Fischer; M. Andreeff; J. McMannis; R. Champlin

Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis
Journal of Clinical Apheresis. 2001;16(2):82-87.

7
109.
2001

Samer Bibawi; Dima Abi-Said; Luis Fayad; Paolo Anderlini; Naoto T. Ueno; Rakesh Mehra; Issa Khouri; Sergio Giralt; James Gajewski; Michelle Donato; et al.

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia
American Journal of Hematology. 2001;67(4):227-233.

17
110.
2001

F. Ravandi; H. Kantarjian; A. Cohen; M. Davis; S. O'Brien; P. Anderlini; B. Andersson; D. Claxton; M. Donato; J. Gajewski; et al.

Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: Results of a phase I study
Bone Marrow Transplantation. 2001;27(12):1221-1225.

28
111.
2001

R. Champlin; I. Khouri; P. Anderlini; J. Gajewski; S. Kornblau; J. Molldrem; A. Shimoni; N. Ueno; S. Giralt

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
Bone Marrow Transplantation. 2001;27(SUPPL. 2):S13-S22.

24
112.
2001

S. Konoplev; R.E. Champlin; S. Giralt; N.T. Ueno; I. Khouri; I. Raad; K. Rolston; K. Jacobson; J. Tarrand; M. Luna; et al.

Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients
Bone Marrow Transplantation. 2001;27(8):877-881.

37
113.
2000

Chy-Myong Seong; Sergio Giralt; Hagop Kantarjian; Jingping Xu; Jolynn Swantkowski; Kimberley Hayes; Armand B. Glassman; Issa Khouri; Martin Korbling; Peter Thall; et al.

Early detection of relapse by fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia
Journal of Clinical Oncology. 2000;18(9):1831-1836.

21
114.
2000

A. Shimoni; S. Giralt; I. Khouri; R. Champlin

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.
Current oncology reports. 2000;2(2):132-139.

15
115.
2000

R. Champlin; van Besien K; S. Giralt; I. Khouri

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
Current oncology reports. 2000;2(2):182-191.

4
116.
2000

Gabriel N. Hortobagyi; Aman U. Buzdar; Richard L. Theriault; Vicente Valero; Debra Frye; Daniel J. Booser; Frankie A. Holmes; Sergio Giralt; Issa Khouri; Borje Andersson; et al.

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
Journal of the National Cancer Institute. 2000;92(3):225-233.

149
117.
2000

Donna Przepiorka; Rima Saliba; Karen Cleary; Harald Fischer; Richard Tonai; Herbert Fritsche; Issa F. Khouri; Jody Folloder; Naoto T. Ueno; Rakesh Mehra; et al.

Tacrolimus Does Not Abrogate the Increased Risk of Acute Graft-Versus-Host Disease after Unrelated-Donor Marrow Transplantation with Allelic Mismatching at HLA-DRB1 and HLA-DQB1
Biology of Blood and Marrow Transplantation. 2000;6(2 A):190-197.

13
118.
2000

Richard Champlin; Issa Khouri; Avichai Shimoni; James Gajewski; Steven Kornblau; Jeffrey Molldrem; Naoto Ueno; Sergio Giralt; Paolo Anderlini

Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
British Journal of Haematology. 2000;111(1):18-29.

145
119.
2000

Jose Rodriguez; Michael J. Keating; Susan O'Brien; Richard E. Champlin; Issa F. Khouri

Allogeneic haematopoietic transplantation for Richter's syndrome
British Journal of Haematology. 2000;110(4):897-899.

29
120.
2000

P. Anderlini; S. Giralt; B. Andersson; N.T. Ueno; I. Khouri; S. Acholonu; A. Cohen; M.J. Körbling; J. Manning; J. Romaguera; et al.

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
Bone Marrow Transplantation. 2000;26(6):615-620.

68
121.
2000

J.E. Romaguera; I.F. Khouri; H.M. Kantarjian; F.B. Hagemeister; M.A. Rodriguez; P. McLaughlin; A.H. Sarris; A. Younes; J. Rodriguez; F Cabanillas

Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients
Leukemia and Lymphoma. 2000;39(1-2):77-85.

42
122.
2000

M. De Lima; K. Van Besien; J. Gajewski; I. Khouri; B. Andersson; M. Korbling; R. Champlin; S. Giralt

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant
Bone Marrow Transplantation. 2000;26(3):333-338.

8
123.
2000

D. Przepiorka; N.A. Kernan; C. Ippoliti; E.B. Papadopoulos; S. Giralt; I. Khouri; J.-G. Lu; J. Gajewski; A. Durett; K. Cleary; et al.

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
Blood. 2000;95(1):83-89.

181
124.
2000

K. Van Besien; I. Khouri; R. Champlin; P. McCarthy

Allogeneic transplantation for low-grade lymphoma: Long-term follow-up
Journal of Clinical Oncology. 2000;18(3):702-703.

13
125.
2000

Issa Khouri; Rima Saliba; Sergio Giralt; Fredrick Hagemeister; Martin Korbling; Anas Younes; James Gajewski; Naoto Ueno; Paolo Anderlini; Fernando Cabanillas; et al.

Allogeneic hematopoietic transplantation for indolent lymphomas: improved outcome with non-myeloablative versus high dose chemotherapy (HDCT) regimens
Blood. 2000;96(11 PART I):199a.

7
126.
2000

Avichai Shimoni; Issa Khouri; Michèle Donato; Paolo Anderlini; Borje Andersson; Naoto Ueno; Richard Champlin; Sergio Giralt

Allogeneic transplantation with nonmyeloablative or reduced intensity conditioning: The intensity of the conditioning regimen is related to outcome in patients with active disease but not in those in remission at the time of transplantation
Blood. 2000;96(11 PART I):199a.

2
127.
2000

Issa Khouri; Mark Munsell; Salim Yajzi; Susan O'Brien; Sergio Giralt; Martin Korbling; Cindy Ippoliti; Michèle Donato; Michael Keating; Richard Champlin

Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL): The case for early intervention
Blood. 2000;96(11 PART I):205a.

8
128.
1999

Donna Przepiorka; Terry L. Smith; Jody Folloder; Issa Khouri; Naoto T. Ueno; Rakesh Mehra; Martin Körbling; Yang O. Huh; Sergío Giralt; James Gajewski; et al.

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
Blood. 1999;94(4):1465-1470.

142
129.
1999

Richard Champlin; Issa Khouri; Stephen Komblau; Jeffrey Molidrem; Sergio Giralt

Reinventing bone marrow transplantation: Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect
ONCOLOGY. 1999;13(5):621-628.

47
130.
1999

D. Adkins; R. Brown; L. Goodnough; H. Khoury; J. Dipersio; I. Khouri; R. Champlin

Purine analog regimens for allogeneic transplant? [1] (multiple letters)
Journal of Clinical Oncology. 1999;17(6):1958-1960.

0
131.
1999

R. Champlin; I. Khouri; S. Giralt

Graft-vs.-malignancy with allogeneic blood stem cell transplantation: A potential primary treatment modality
Pediatric Transplantation. 1999;3(SUPPL. 1):52-58.

6
132.
1999

M.L. Donato; R.E. Champlin; K.W. Van Besien; M. Korbling; F. Cabanillas; P. Anderlini; J.G. Gajewski; J. Lauppe; A. Durett; B. Andersson; et al.

Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma
Leukemia and Lymphoma. 1999;35(3-4):317-324.

16
133.
1999

I.F. Khouri; M.-S. Lee; J. Romaguera; N. Mirza; H. Kantarjian; M. Korbling; M. Albitar; S. Giralt; B. Samuels; P. Anderlini; et al.

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy
Annals of Oncology. 1999;10(11):1293-1299.

92
134.
1999

R. Champlin; I. Khouri; S. Kornblau; F. Marini; P. Anderlini; N.T. Ueno; J. Molldrem; S. Giralt

Allogeneic hematopoietic transplantation as adoptive immunotherapy: Induction of graft-versus-malignancy as primary therapy
Hematology/Oncology Clinics of North America. 1999;13(5):1041-1057.

26
135.
1999

Richard Champlin; Issa Khouri; Steven Kornblau; Jeffrey Molldrem; Sergio Giralt

Reinventing bone marrow transplantation: Reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy
Current Opinion in Oncology. 1999;11(2):87-95.

54
136.
1999

D. Przepiorka; I. Khouri; C. Ippoliti; N.T. Ueno; R. Mehra; M. Körbling; S. Giralt; J. Gajewski; H. Fischer; M. Donato; et al.

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation
Bone Marrow Transplantation. 1999;24(7):763-768.

43
137.
1999

Richard Champlin; Issa Khouri; Sergio Giralt

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: Induction of graft-vs.-Malignancy as treatment for malignant diseases
Journal of Clinical Apheresis. 1999;14(1):45-49.

4
138.
1999

D. Przepiorka; I. Khouri; P. Thall; R. Mehra; M.-S. Lee; C. Ippoliti; S. Giralt; J. Gajewski; K. Van Besien; B. Andersson; et al.

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia
Bone Marrow Transplantation. 1999;23(10):977-981.

17
139.
1999

D. Przepiorka; K. Van Besien; I. Khouri; F. Hagemeister; B. Samuels; J. Folloder; N.T. Ueno; J. Molldrem; R. Mehra; M. Körbling; et al.

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
Annals of Oncology. 1999;10(5):527-532.

29
140.
1999

S. Giralt; I. Khouri; R. Champlin

Non myeloablative "mini transplants".
Cancer treatment and research. 1999;101:97-108.

28
141.
1998

Issa F. Khouri; Jorge Romaguera; Hagop Kantarjian; J. Lynn Palmer; William C. Pugh; Martin Korbling; Fredrick Hagemeister; Barry Samuels; Alma Rodriguez; Sergio Giralt; et al.

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
Journal of Clinical Oncology. 1998;16(12):3803-3809.

231
142.
1998

Issa F. Khouri; Michael Keating; Martin Körbling; Donna Przepiorka; Paolo Anderlini; Susan O'Brien; Sergio Giralt; Cindy Ippoliti; Brigitte Von Wolff; James Gajewski; et al.

Transplant-lite: Induction of graft-versus-malignancy using fludarabine- based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
Journal of Clinical Oncology. 1998;16(8):2817-2824.

737
143.
1998

Naoto T. Ueno; Gabriela Rondón; Nadeem Q. Mirza; Deborah K. Geisler; Paolo Anderlini; Sergio A. Giralt; Borje S. Andersson; David F. Claxton; James L. Gajewski; Issa F. Khouri; et al.

Allogeneic peripheral-blood progenitor-cell transplantation for poor- risk patients with metastatic breast cancer
Journal of Clinical Oncology. 1998;16(3):986-993.

192
144.
1998

I.F. Khouri; M.J. Keating

High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?
Annals of Oncology. 1998;9(2):131-132.

5
145.
1998

Donna Przepiorka; Sergio Giralt; Issa Khouri; Richard Champlin; Carlos Bueso-Ramos

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases
American Journal of Hematology. 1998;57(1):24-28.

45
146.
1998

Uday Popat; Donna Przepiork; Richard Champlin; William Pugh; Kamal Amin; Rakesh Mehra; Jose Rodriguez; Sergio Giralt; Jorge Romaguera; Alma Rodriguez; et al.

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome
Journal of Clinical Oncology. 1998;16(1):63-69.

46
147.
1998

Issa F. Khouri; Michael J. Keating; Richard Champlin

Hematopoietic stem cell transplantation for chronic lymphocytic leukemia
Current Opinion in Hematology. 1998;5(6):454-459.

11
148.
1998

R. Champlin; I. Khouri; S. Giralt

Induction of graft-vs-malignancy as a primary therapeutic modality
Experimental Hematology. 1998;26(8):816.

0
149.
1997

M. Woo; D. Przepiorka; C. Ippoliti; D. Warkentin; I. Khouri; H. Fritsche; M. Körbling

Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation
Bone Marrow Transplantation. 1997;20(12):1095-1098.

49
150.
1997

Cindy Ippoliti; Richard Champlin; Najla Bugazia; Donna Przepiorka; Joyce Neumann; Sergio Giralt; Issa Khouri; James Gajewski

Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies
Journal of Clinical Oncology. 1997;15(11):3350-3354.

25
151.
1997

C. Ippoliti; A. Morgan; D. Warkentin; K. Van Besien; R. Mehra; I. Khouri; S. Giralt; J. Gajewski; R. Champlin; B. Andersson; et al.

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir
Bone Marrow Transplantation. 1997;20(6):491-495.

17
152.
1997

Koen Van Besien; Peter Thall; Martin Korbling; William C. Pugh; Issa Khouri; Rakesh Mehra; Sergio Giralt; Paolo Anderlini; Kamal Amin; Nadeem Mirza; et al.

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: Experience in 44 consecutive patients
Biology of Blood and Marrow Transplantation. 1997;3(3):150-156.

20
153.
1997

Sergio Giralt; Elihu Estey; Maher Albitar; Koen Van Besien; Gabriela Rondón; Paolo Anderlini; Susan O'Brien; Issa Khouri; James Gajewski; Rakesh Mehra; et al.

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
Blood. 1997;89(12):4531-4536.

877
154.
1997

James Gajewski; David Gjertson; Michael Cecka; Richard Tonai; Donna Przepiorka; Lynne Hunt; Sergio Giralt; Ka Wah Chan; Stephen Feig; Mary Territo; et al.

The impact of T-cell depletion on the effects of HLA DRβ1 and DQβ allele matching in HLA serologically identical unrelated donor bone marrow transplantation
Biology of Blood and Marrow Transplantation. 1997;3(2):76-82.

21
155.
1997

K.W. Van Besien; M. De Lima; S.A. Giralt; D.F. Moore Jr.; I.F. Khouri; G. Rondón; R. Mehra; B.S. Andersson; C. Dyer; K. Cleary; et al.

Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect
Bone Marrow Transplantation. 1997;19(10):977-982.

162
156.
1997

D. Przepiorka; P. Anderlini; C. Ippoliti; I. Khouri; T. Fietz; P. Thall; R. Mehra; S. Giralt; J. Gajewski; A.B. Deisseroth; et al.

Allogeneic blood stem cell transplantation in advanced hematologic cancers
Bone Marrow Transplantation. 1997;19(5):455-460.

75
157.
1997

S. Giralt; D. Weber; M. Colome; M. Dimopoulos; R. Mehra; K. Van Besien; J. Gajewski; B. Andersson; I. Khouri; D. Przepiorka; et al.

Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
Journal of Clinical Oncology. 1997;15(2):667-673.

31
158.
1997

M. De Lima; K.W. Van Besien; S.A. Giralt; I.F. Khouri; R. Mehra; B.S. Andersson; D. Przepiorka; J.L. Gajewski; M. Korbling; R.E. Champlin

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma
Bone Marrow Transplantation. 1997;19(2):121-127.

61
159.
1997

Q. Nguyen; R. Champlin; K. Rolston; I. Raad; I. Khouri; D. Hecht; C. Ippoliti; N. Mirza; K. Jacobson; J. Tarrand; et al.

CMV pneumonia in adult autologous blood and marrow transplant recipients
Clinical Infectious Diseases. 1997;25(2):374.

0
160.
1997

I. Khouri; M. Keating; M. Körbling; D. Przepiorka; P. Anderlini; S. O'Brien; B. Von Wolff; S. Giralt; J. Gajewski; et al.

Induction of graft-versus-leukemia using flu-darabine-based allogeneic mini-transplants as treatment for lymphoid malignancies
Experimental Hematology. 1997;25(8):735.

0
161.
1997

Issa F. Khouri; Donna Przepiorka; Koen Van Besien; Susan O'Brien; Judy L. Palmer; Susan Lerner; Rakesh C. Mehra; Huibert M. Vriesendorp; Borje S. Andersson; Sergio Giralt; et al.

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: Timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease
British Journal of Haematology. 1997;97(2):466-473.

82
162.
1996

Donna Przepiorka; Cindy Ippoliti; Issa Khouri; Paolo Anderlini; Rakesh Mehra; Sergio Giralt; James Gajewski; Herbert Fritsche; Albert B. Deisseroth; Karen Cleary; et al.

Allogeneic transplantation for advanced leukemia: Improved short-term outcome with blood stem cell grafts and tacrolimus
Transplantation. 1996;62(12):1806-1810.

40
163.
1996

Donna Przepiorka; Cindy Ippoliti; Issa Khouri; Michael Woo; Rakesh Mehra; Donna Le Bherz; Sergio Giralt; James Gajewski; Harald Fischer; Herbert Fritsche; et al.

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation
Blood. 1996;88(11):4383-4389.

75
164.
1996

M. Körbling; K.W. Chan; P. Anderlini; D. Seong; A. Durett; A. Langlinais; D. Przepiorka; J. Gajewski; P. Miller; J. Sundberg; et al.

Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors
Bone Marrow Transplantation. 1996;18(5):885-890.

30
165.
1996

I. Khouri; R. Champlin

Allogenic bone marrow transplantation in chronic lymphocytic leukemia.
Annals of internal medicine. 1996;125(9):780.

5
166.
1996

G. Rondón; S. Giralt; Y. Huh; I. Khouri; B. Andersson; M. Andreeff; R. Champlin

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia
Bone Marrow Transplantation. 1996;18(3):669-672.

106
167.
1996

I.F. Khouri; H.M. Kantarjian; M. Talpaz; S. Giralt; M.O. Rios; J.P. Hester; R.E. Champlin; A.B. Deisseroth

Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: The MD Anderson experience
Bone Marrow Transplantation. 1996;17(5):775-779.

26
168.
1996

Koen W. Van Besien; Rakesh C. Mehra; Sergio A. Giralt; Hagop M. Kantarjian; William C. Pugh; Issa F. Khouri; Young Moon; Pat Williams; Borje S. Andersson; Donna Przepiorka; et al.

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology
American Journal of Medicine. 1996;100(3):299-307.

94
169.
1996

I. Khouri; Ml Kcating; B. Andersson; S. O'Brien; M. Körbling; R. Champlm

Fludarabine (famp)-based chemotherapy at conventional doses allows engraftment of allogeneic (allo) peripheral blood progenitor cell (pbpc) transplantation in chronic lymphocytic leukemia (cll)
Experimental Hematology. 1996;24(9):1046.

0
170.
1996

Issa F. Khouri; Cindy Ippoliti; James Gajewski; Donna Przepiorka; Richard E. Champlin

Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin
American Journal of Hematology. 1996;52(4):313-315.

12
171.
1996

K. van Besien; D. Przeplorka; R. Mehra; S. Giralt; I. Khouri; J. Gajewski; B. Andersson; R. Champlin

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies
Journal of Clinical Oncology. 1996;14(11):3036-3042.

18
172.
1996

M. Korbling; P. Anderlini; A. Durett; F. Maadani; P. Bojko; D. Seong; S. Giralt; I. Khouri; B. Andersson; R. Mehra; et al.

Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34⁺ and CD34⁺ Thy-1(dim) CD38^- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation
Bone Marrow Transplantation. 1996;18(6):1073-1079.

14
173.
1995

S. Giralt; S. O'Brien; M. Talpaz; K. Van Besien; Chan Ka-Wah; G. Rondon; B. Andersson; R. Mehra; I. Khouri; E. Estey; et al.

Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation
Cytokines and Molecular Therapy. 1995;1(2):115-122.

7
174.
1995

D. Przepiorka; K.-W. Chan; R.E. Champlin; S.J. Culbert; D. Petropoulos; C. Ippoliti; I. Khouri; Y.O. Huh; H. Vreisendorp; A.B. Deisseroth; et al.

Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients
Bone Marrow Transplantation. 1995;16(6):737-741.

5
175.
1995

S. Giralt; J. Hester; Y. Huh; C. Hirsch-Ginsberg; G. Rondon; D. Seong; M. Lee; J. Gajewski; K. Van Besien; I. Khouri; et al.

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
Blood. 1995;86(11):4337-4343.

250
176.
1995

C. Ippoliti; D. Przepiorka; R. Mehra; J. Neumann; J. Wood; D. Claxton; J. Gajewski; I. Khouri; K. Van Besien; B. Andersson; et al.

Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation
Urology. 1995;46(6):811-815.

16
177.
1995

K.W. Van Besien; I.F. Khouri; S.A. Giralt; P. McCarthy; R. Mehra; B.S. Andersson; D. Przepiorka; J.L. Gajewski; N. Bellare; et al.

Allogeneic bone marrow transplantation for refractory and recurrent low- grade lymphoma: The case for aggressive management
Journal of Clinical Oncology. 1995;13(5):1096-1102.

102
178.
1995

M. Talpaz; H. Kantarjian; J. Liang; L. Calvert; J. Hamer; P. Tibbits; A. Durett; D. Claxton; S. Giralt; et al.

Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells
Blood. 1995;85(11):3257-3263.

48
179.
1995

D. Przepiorka; R. Nath; C. Ippoliti; R. Mehra; E. Hagemeister; K. Diener; M. Dimopoulos; S. Giralt; I. Khouri; B. Samuels; et al.

A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma
Leukemia and Lymphoma. 1995;17(5-6):427-433.

20
180.
1995

K. Van Besien; J. Tabocoff; M. Rodriguez; B. Andersson; R. Mehra; D. Przepiorka; M. Dimopoulos; S. Giralt; S. Suki; I. Khouri; et al.

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: Durable complete remissions, but a high rate of regimen-related toxicity
Bone Marrow Transplantation. 1995;15(4):549-555.

48
181.
1994

Sergio A. Giralt; Charles F. LeMaistre; Huib M. Vriesendorp; Borje S. Andersson; Meletios Dimopoulos; James Gajewski; Koen Van Besien; Rakesh Mehra; Donna Przepiorka; Issa Khouri; et al.

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies
Journal of Clinical Oncology. 1994;12(9):1923-1930.

37
182.
1994

Issa F. Khouri; Michael J. Keating; Huibert M. Vriesendorp; Christopher L. Reading; Donna Przepiorka; Yang O. Huh; Borje S. Andersson; Koen W. Van Besien; Rakesh C. Mehra; Sergio A. Giralt; et al.

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results
Journal of Clinical Oncology. 1994;12(4):748-758.

144
183.
1994

H.M. Kantarjian; M. Talpaz; B. Andersson; I. Khouri; S. Giralt; M.B. Rios; R. Champlin; J. Hester; A.B. Deisseroth

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia
Bone Marrow Transplantation. 1994;14(1):57-61.

17
184.
1994

D. Przepiorka; Y.O. Huh; I. Khouri; C. Reading; J. Hester; M. Marshall; R.E. Champlin

Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Progress in clinical and biological research. 1994;389:557-563.

6
185.
1994

J.F. Seymour; I.F. Khouri; R.E. Champlin; M.J. Keating; M.G. Burkett

Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation: Case report and review
American Journal of Clinical Oncology: Cancer Clinical Trials. 1994;17(4):360-368.

9
186.
1994

D. Przepiorka; C. Ippoliti; J. Koberda; K.-W. Chan; I.F. Khouri; H.E. Fischer; Y.O. Huh; S.M. Escudier; D. Seong; M. Davis; et al.

Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation
Transplantation. 1994;58(7):858-860.

5
187.
1992

Marc Etkin; Marylynne Filaccio; Debra Ellerson; Soon-Pal Suh; David Claxton; Eugenia Gaozza; Malcolm Brenner; Robert Moen; John Belmont; Kateri A. Moore; et al.

Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals
Human Gene Therapy. 1992;3(2):137-145.

5
188.
1992

M. Lee; I. Khouri; R. Champlin; H. Kantarjian; M. Talpaz; J. Trujillo; E. Freireich; A. Deisseroth; S. Stass

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation
British Journal of Haematology. 1992;82(4):708-714.

36
189.
1992

T. Yuan; Y.Q. Zhou; C.V. Herst; C. Reading; D. Ellersen; M. Etkin; I. Khouri; H. Kantarjian; M. Talpaz; et al.

Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation.
Progress in clinical and biological research. 1992;377:227-230.

5

Issa F Khouri Stem Cell Transplantation, Cancer Medicine

Issa F Khouri

Issa F Khouri
Stem Cell Transplantation, Cancer Medicine